Connect with us

Business

Why Pfizer Stock Dropped Today – Motley Fool

Investors are still waiting on data from Pfizer’s ongoing clinical trial for its coronavirus vaccine candidate.

Published

on

post featured image
ADVERTISEMENT

What happened
Shares of pharma giant Pfizer(NYSE:PFE) fell by as much as 5.6% on Wednesday and closed the day’s trading session down by 5.3%. While the broader stock market is feeling the pressure of a new surge in COVID-19 cases worldwide, one would expect Pfizer, a leader in the COVID-19 vaccine race, to benefit from these developments. However, investors are getting impatient with Pfizer, which has yet to release any data from its ongoing late-stage clinical trial for its coronavirus vaccine…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Here’s What’s Pushing Tesla Stock Toward $600 — and Beyond – Motley Fool
post featured image
Coronavirus: Second-hand car website becomes latest ‘unicorn’ – BBC News
post featured image
Bitcoin price, altcoins and the Dow set record highs as bulls run the market – Cointelegraph